• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

    11/7/24 6:00:00 AM ET
    $HAE
    Medical/Dental Instruments
    Health Care
    Get the next $HAE alert in real time by email

    Financial release accessible online

    BOSTON, Nov. 7, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its second quarter fiscal year 2025, which ended September 28, 2024, are available on its Investor Relations website.

    The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 7, 2024. The conference call and webcast can be accessed with the following information:

    • Teleconference link: https://register.vevent.com/register/BI3c9f473811f94c489025845778f9dabc
    • Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
    • A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/rcm5foqd

    In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.

    Direct link to 2Q FY25 Earnings Release:

    https://haemonetics.gcs-web.com/static-files/a28cb934-1e51-4489-9c9f-1a3f68dc7f5a

    A replay of the conference call and webcast will be available for one year beginning on November 7, 2024, at 11:00 a.m. ET using the conference call webcast link provided in this press release.

    ABOUT HAEMONETICS

    Haemonetics (NYSE:HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

    Investor Contacts:



    Olga Guyette, Vice President-Investor Relations & Treasury

    David Trenk, Manager-Investor Relations

    (781) 356-9763

    (203) 733-4987

    [email protected]

    [email protected]

     

    Media Contact:



    Josh Gitelson, Sr. Director-Global Communications



    (781) 356-9776



    [email protected]



     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-fiscal-year-2025-earnings-release-available-on-investor-relations-website-302298494.html

    SOURCE Haemonetics Corporation

    Get the next $HAE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HAE

    DatePrice TargetRatingAnalyst
    2/7/2025$95.00 → $68.00Neutral → Underperform
    BofA Securities
    12/6/2024$116.00Overweight
    Analyst
    11/8/2024$120.00Outperform → Strong Buy
    Raymond James
    9/13/2024$116.00Buy
    CL King
    9/11/2024$85.00Neutral
    BofA Securities
    9/10/2024$112.00Buy
    BTIG Research
    6/12/2024$112.00Hold → Buy
    Needham
    10/13/2022$90.00Buy
    Mizuho
    More analyst ratings